JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"
Summary of Three Toxicity Study of Repeated Intravenous Infusion of Exatecan Derivative-ADCs to Cynomolgus Monkey
2026.07.28
Consideration of Implementation for Postmarketing Carcinogenicity Studies Based on a Retrospective Analysis of Approved New Drugs by US FDA in the Past Ten Years
2026.07.28
The Importance of Using Pathogen-Free NHP in Preclinical Studies-trifold brochure
2026.07.28
JOINN PQRT Flyer
2026.07.28
JOINN Non-Clinical trifold - Disease models
2026.07.28
JOINN Non-Clinical Flyer- Medical Device Platform
2026.07.28
JOINN Non-Clinical Flyer - Developmental and Reproductive Toxicology